← Back to Patent Explorer
US5244649A Expired / Lapsed US ⏱️ 0.0 years remaining

Production of hematite pigments in the form of platelets

Assignee: BASF SE
•
Filing: 1990-08-23
•
Granted: 1993-09-14
•
Expires: 2010-08-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Iron oxides in the form of platelets are produced by hydrothermal treatment of aqueous suspensions containing iron(III) hydroxide or oxide hydrates in the presence of alkali metal hydroxides and of aluminum and/or silicon compounds in two stages. The normality of the alkali is from 0 2 to 2 N in the first stage and is increased by from 0.2 to 2.5 in the second stage. The two-stage process according to the invention makes it possible to produce hematite pigments which are in the form of platelets, have increased luster, larger particle diameter, improved dispersibility and color hues which can be adjusted as desired.

Inventors

  • 👤 Werner Ostertag
  • 👤 Christoph Schwidetzky
  • 👤 Norbert Mronga

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 13:46
CPC Classifications
C; C09; C09C; C09C1/00; C09C1/22; C09C1/24; C09C1/245; C01; C01P; C01P2004/00; C01P2004/20; C01P2006/00; C01P2006/60; C01P2006/62

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 110 words
A process for producing α-Fe 2 O 3 (hematite) in the form of platelets by the hydrothermal treatment of an aqueous suspension containing from 1 to 20% by weight of iron(III) hydroxide or oxide hydrate solids in the presence of alkali metal hydroxide and of aluminum and/or silicon compounds, which comprises: carrying out the hydrothermal treatment in two stages at a temperature of from 150° to 360° C. and within a time of 1 minute to 40 hours, with the proviso that the normality of the alkali is from 0.2 to 2 N in the first stage and is increased by from 0.2 to 2.5 N in the second stage.
Claim 2
Dependent Claim 110 words
A process for producing α-Fe 2 O 3 (hematite) in the form of platelets by the hydrothermal treatment of an aqueous suspension containing from 1 to 20% by weight of iron(III) hydroxide or oxide hydrate solids in the presence of alkali metal hydroxide and of aluminum and/or silicon compounds, which comprises: carrying out the hydrothermal treatment in two stages at a temperature of from 150° to 360° C. and within a time of 1 minute to 40 hours, with the proviso that the normality of the alkali is from 0.2 to 2 N in the first stage and is increased by from 0.2 to 2.5 N in the second stage.
Claim 3
Dependent Claim 29 words
The process of claim 1, wherein the temperature in the first stage is from 170° to 360° C. and in the second stage is from 150° to 360° C.
Claim 4
Dependent Claim 42 words
The process of claim 1, wherein the hydrothermal treatment in the second stage is carried out in the presence of compounds, which are soluble in alkalis, of the elements silicon, aluminum, arsenic, antimony, boron, zirconium, phosphorus, titanium, chromium, manganese, molybdenum and tungsten.
Claim 5
Dependent Claim 20 words
The process of claim 1, wherein the second stage is carried out in the same vessel as the first stage.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-09-13 1997-03-15 1997-09-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-09-13 2001-03-15 2001-09-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-09-13 2005-03-15 2005-09-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag